Q2 2024 Holdings
Filed 2024-08-14 | 46 holdings | $334.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $33.5M | 1,349,980 | 10.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $30.2M | 9,570,000 | 9.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $21.1M | 2,000,000 | 6.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $20.3M | 800,000 | 6.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $18.5M | 170,000 | 5.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $18.3M | 4,352,700 | 5.5% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $18.0M | 4,670,000 | 5.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.0M | 629,900 | 3.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.5M | 230,000 | 3.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.3M | 551,544 | 3.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $10.8M | 314,800 | 3.2% |
| Kelly Svcs Inc(KELYA) | CL A | 488152208 | $10.5M | 492,340 | 3.2% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $10.0M | 1,180,000 | 3.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.6M | 325,000 | 2.6% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $7.1M | 369,261 | 2.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $7.0M | 2,352,633 | 2.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.6M | 275,000 | 2.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.5M | 2,750,000 | 1.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.1M | 115,000 | 1.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $5.9M | 286,926 | 1.8% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $5.8M | 200,216 | 1.7% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $5.7M | 205,000 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.6M | 49,317 | 1.7% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $5.3M | 1,489,525 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.2M | 500,000 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.7M | 27,000 | 1.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.5M | 385,000 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.5M | 398,700 | 0.7% |
| CVS Health Corp(CVS) | COM | 126650100 | $2.4M | 40,000 | 0.7% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $2.4M | 30,000 | 0.7% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $2.0M | 2,488,418 | 0.6% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $1.9M | 14,000 | 0.6% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $1.8M | 261,400 | 0.5% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $1.7M | 9,373 | 0.5% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $1.7M | 96,065 | 0.5% |
| Mural Oncology PUB LTD Co | ORD SHS | G63365103 | $1.5M | 475,458 | 0.4% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $1.5M | 12,500 | 0.4% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.1M | 67,461 | 0.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $1.0M | 59,542 | 0.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $953.5K | 49,021 | 0.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $826.9K | 1,075,000 | 0.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $786.5K | 65,000 | 0.2% |
| Aileron Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $734.1K | 265,000 | 0.2% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $704.0K | 550,000 | 0.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $559.7K | 124,377 | 0.2% |
| Kezar Life Sciences Inc | COM | 49372L100 | $33.6K | 56,080 | 0.0% |